- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02291952
Development of Countermeasures Against Adverse Metabolic Effects of Shift Work
March 18, 2020 updated by: Frank AJL Scheer, PhD, Brigham and Women's Hospital
The goal of this application is to determine whether changing the timing of food intake prevents the adverse metabolic effects of circadian misalignment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Shift work is associated with circadian misalignment and an increased risk for the development diabetes, obesity, and cardiovascular disease.
This research will determine whether changing the feeding schedule can prevent metabolic alterations that can lead to the abovementioned disorders.
This research will provide mechanistic insight and may provide a novel therapeutic approach against the increased risk for diabetes, obesity, and cardiovascular disease among shift workers.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI between 18.5 and 29.9 kgm-2
- Healthy adults with regular sleep-wake timing
- Non-smokers
- Completion of medical and psychological screening tests
- Able to spend 14 consecutive days in the sleep laboratory
Exclusion Criteria:
- BMI <18.5 or > 29.9 kgm-2
- History of neurological or psychiatric disorder
- History of sleep disorder or regular use of sleep-promoting medication
- Current prescription, herbal, or over-the-counter medication use
- Traveling across 2 or more time zones within past 3 months
- Donating blood within past 8 weeks
- Worked night or rotating shift work within past 3 years
- Hearing impairment
- Drug or alcohol dependency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
During Forced Desynchrony sleep and wake will occur at different circadian phases, while meals are restricted to the biological day.
|
|
|
Other: Control
During Forced Desynchrony sleep and wake, as well as meals, will occur at different circadian phases.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in plasma leptin levels across sleep/wake cycle
Time Frame: During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
|
Frequent blood samples
|
During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
|
|
Change in circadian profile of plasma leptin
Time Frame: During constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)
|
Frequent blood samples
|
During constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)
|
|
Change in glucose tolerance
Time Frame: During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
|
Frequent blood samples before and after standardized meals
|
During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
|
|
Change in circadian profile of plasma glucose levels
Time Frame: During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
|
Frequent blood samples
|
During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
|
|
Change in plasma insulin levels after standardized test meal
Time Frame: During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
|
Frequent blood samples before and after standardized meals
|
During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
|
|
Change in circadian profile of plasma insulin levels
Time Frame: During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
|
Frequent blood samples
|
During circadian alignment (Day 7) and circadian misalignment (Day 10-11)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
o Change in circadian phase markers, such as from core body temperature, melatonin, and cortisol
Time Frame: Core temperature and frequent blood samples
|
Core temperature sensor throughout protocol, days 1-14.
Frequent blood samples during constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)
|
Core temperature and frequent blood samples
|
|
Changes circadian rhythm in resting energy expenditure
Time Frame: During constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)
|
Indirect calorimetry
|
During constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)
|
|
Change in hunger and appetite, mood, and cognitive performance
Time Frame: Tests taken throughout the protocol, days 1-14
|
Subjective hunger ratings and cognitive tests performed via computer interface
|
Tests taken throughout the protocol, days 1-14
|
|
Changes in microbiota, gene expression, epigenetic or proteomic markers
Time Frame: samples taken during forced desychrony (days 7-11) and the constant routine protocols (days 3-4 and 11-13)
|
Frequent blood samples and saliva samples
|
samples taken during forced desychrony (days 7-11) and the constant routine protocols (days 3-4 and 11-13)
|
|
Changes in sleep
Time Frame: sleep periods following day 1, days 6-7 and days 10-11
|
Polysomnography
|
sleep periods following day 1, days 6-7 and days 10-11
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Frank A Scheer, PhD, Brigham and Women's Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 19, 2015
Primary Completion (Actual)
August 29, 2018
Study Completion (Actual)
August 29, 2018
Study Registration Dates
First Submitted
November 12, 2014
First Submitted That Met QC Criteria
November 12, 2014
First Posted (Estimate)
November 17, 2014
Study Record Updates
Last Update Posted (Actual)
March 19, 2020
Last Update Submitted That Met QC Criteria
March 18, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01HL118601 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Circadian Dysregulation
-
Stanford UniversityRecruitingCircadian DysregulationUnited States
-
University of California, BerkeleyCompletedCircadian DysregulationUnited States
-
Laura Beth KalvasNationwide Children's HospitalRecruitingLight Exposure | Circadian Dysregulation | Pediatric Critical IllnessUnited States
-
University of California, BerkeleyActive, not recruitingCircadian DysregulationUnited States
-
VA Palo Alto Health Care SystemSeoul SemiconductorCompletedSleep | Mood | Circadian DysregulationUnited States
-
University of Nebraska LincolnRush University Medical Center; University of NebraskaCompletedObesity | Circadian DysregulationUnited States
-
Northwestern UniversityRush UniversityCompletedPreDiabetes | Circadian DysregulationUnited States
-
Rush University Medical CenterCompletedDelirium | Critical Illness | Circadian DysregulationUnited States
-
TakedaCompletedCircadian DysregulationUnited States
-
University of UtahRecruitingSleep | Sleep Deprivation | Circadian Rhythm | Light Exposure | Insufficient Sleep | Sleep Hygiene | Circadian Dysregulation | Metabolism Changes | Lifestyle Factors | Sleep Hygiene, Inadequate | Circadian MisalignmentUnited States
Clinical Trials on Meal schedule
-
Brigham and Women's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Overweight | Prediabetes | MealsUnited States
-
Lexicon PharmaceuticalsCompleted
-
University of OxfordCompleted
-
China Medical University HospitalCompleted
-
University of California, Los AngelesRecruiting
-
Ontario Clinical Oncology Group (OCOG)Canadian Breast Cancer Research AllianceCompleted
-
Essentia HealthMinnesota Cancer Clinical Trials NetworkActive, not recruitingMaintenance of Implanted Port DevicesUnited States
-
Rutgers, The State University of New JerseyRecruitingIncreasing Functional Communicative Behavior | Decreasing Destructive BehaviorUnited States
-
Ontario Clinical Oncology Group (OCOG)Completed
-
Maria Sklodowska-Curie National Research Institute...National Center for Research and Development, PolandCompleted